HOME >> BIOLOGY >> NEWS
Chromosomal Abnormalities Key For Prediting Leukemia Outcome

COLUMBUS, Ohio -- One of the longest running studies to follow leukemia patients has confirmed that chromosomal abnormalities seen in many of these patients can help determine treatment and predict the likelihood of cure.

The study is a 15-year follow-up of 628 patients with acute myeloid leukemia (AML). This was the first large group of AML leukemia patients for which information on chromosomal abnormalities was prospectively collected. The study of chromosomal abnormalities is known as cytogenetics.

“This study provides stronger evidence for the correlation between cure and a patient’s cytogenetics, and between cytogenetics, survival, and the treatment that patients receive,” said Clara Bloomfield, director of the Ohio State University's Comprehensive Cancer Center and William G. Pace III Professor of Cancer Research.

“It also showed that the majority of patients who were continuously disease-free for five years after diagnosis were cured.”

The study, which was led by Bloomfield, appears in a recent supplement to the journal Cancer. The 628 patients, median age 49 years, had primary AML that was diagnosed between 1980 and 1982.

Median survival of the patients was 7 months, although survival varied significantly according to the chromosomal abnormalities present. For example, patients whose leukemia cells showed a loss of, or damage to, one of the two copies of chromosome 5 or 7 had a median survival of 3 months, while those showing damage to chromosome 16 had a median survival of 18 months.

Of the 628 AML patients in the study, 56 (9 percent) were alive five years after diagnosis. Of these, nine died of AML between 5 and 10 years, one died of AML 11 years after diagnosis, and 7 seven were unavailable for further follow-up.

This left 39 patients, or 6.2 percent, alive 10 to 15 years after their AML diagnosis.

“Thes
'"/>

Contact: Clara Bloomfield
Bloomfield-1@medctr.osu.edu
(614) 293-7048
Ohio State University
26-Mar-1998


Page: 1 2 3

Related biology news :

1. Protecting the rice bowl: Chromosomal mapping of the rice blast fungus
2. Researchers Discover The Pattern Of Inheritance Of Non-Chromosomal DNA
3. Abnormalities in cellular anchoring protein cause fatal heart syndrome
4. Abnormalities in stress hormone response among alcoholics
5. Multi-Center Study Provides Guidelines For Genetic Testing In Women With Breast Cancer: BRCA Abnormalities Multiply Risk Of Ovarian Cancer
6. UB Fertility Researchers Find They Can Predict Pregnancy By Assessing Two Sperm Abnormalities
7. Leukemia stem cells identified by Stanford researchers
8. Newly Discovered Viral Gateway Into Cells Could Play Role In Diagnosis And Treatment Of Leukemia, HIV And Other Viral Diseases
9. Hormone Control Of Rare Leukemia Sheds Light On Molecular Basis Of Cancer
10. New Gene Alteration Find Points To Aggressive Leukemia Treatment
11. Outcome for acute lymphoblastic leukemia linked to gene expression patterns

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/6/2019)... ... June 05, 2019 , ... ... exclusive financial advisor to Pathologists Bio-Medical Laboratories (PBM) on its recent acquisition by ... pathology platform that provides services to more than one dozen hospitals and surgery ...
(Date:6/4/2019)... ... June 04, 2019 , ... Most ... features of seizure risk signals, usually based on variations of amplitude, frequency or ... only acceptable diagnostic methodology due to the complexity and variability of the signal, ...
(Date:5/31/2019)... , ... May 29, 2019 , ... ... on Mac, Windows and mobile, announces the launch of version 13.1. The new ... latest Android Management API, and supports Apple’s spring release functionality. Version 13.1 builds ...
Breaking Biology News(10 mins):
(Date:7/17/2019)... ... July 16, 2019 , ... ... development and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), an AveXis gene therapy treatment ... company, will have dedicated manufacturing space at the new, state-of-the-art commercial manufacturing ...
(Date:7/9/2019)... ... July 08, 2019 , ... ... company’s SmartLight Indicator was recognized as the 2019 Innovative Product of the Year ... The prestigious awards were during Sensors Expo & Conference 2019, held ...
(Date:6/18/2019)... ... June 18, 2019 , ... Personalized Stem Cells, Inc (“PSC”), ... to the FDA for use of a person’s own adipose-derived stem cells to treat ... in the knee. This IND is the first of several planned clinical trials ...
(Date:6/11/2019)... ... 10, 2019 , ... DeepDyve and IOP ... to DeepDyve’s rental service for peer-reviewed journals. , IOPP’s portfolio represents an ... 20 million articles, sourced from more than 15,000 journals. , “By partnering with ...
Breaking Biology Technology:
Cached News: